ketorolac tromethamine 4 MG/ML Ophthalmic Solution

What the CMS Formulary Data Shows for ketorolac tromethamine 4 MG/ML Ophthalmic Solution

Per the CMS 2026 Part D formulary file, ketorolac tromethamine 4 MG/ML Ophthalmic Solution (RxNorm concept RXCUI 860103, generic name ketorolac tromethamine) appears on 265 distinct formulary files spanning 4,838 Medicare Part D plan offerings - 95.5% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.2.

Real-world access to ketorolac tromethamine 4 MG/ML Ophthalmic Solution depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 14.3% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 951,621 Part D beneficiaries filled ketorolac tromethamine 4 MG/ML Ophthalmic Solution in 2023, with total plan-and-beneficiary spending of $40,351,229 and an average per-beneficiary annual cost of $42.40. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry ketorolac tromethamine 4 MG/ML Ophthalmic Solution today.